IGF1R and Alzheimer disease: To retard human aging and age-related diseases, inhibition of insulin-like growth factor 1 (IGF1) has been proposed, and several studies have shown that neuron-specific deletion of IGF1R confers neuroprotection and improves behavior in AD transgenic mice46–48.